Delivery Order SPE2DB22D2206-SPE2DB25FHS85
Award Date 7/1/25
Potential Completion Date 7/2/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Candesartan Cilexetil 32 mg tablets. The contract has a ceiling value of $1,783.96 and a performance period ending on July 7, 2025. It is a firm-fixed-price contract, with no set-aside designation indicated. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Candesartan Cilexetil 32 mg tablets. The contract has a firm fixed price ceiling value of $9,059.79 and a period of performance extending to October 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Candesartan Cilexetil 16 mg tablets. The contract has a ceiling value of $7,188.72 and an ultimate completion date of February 20, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 32 mg tablets in 90-count packages, with a ceiling value of $6,296.40 and an ultimate completion date of January 8, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 16 mg tablets, with a ceiling value of $3,555.50 and a period of performance through May 28, 2025. The contract is a firm-fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Candesartan Cilexetil 16 mg tablets, a prescription medication. The contract has a ceiling value of $39,839.69 and an ultimate completion date of September 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Candesartan Cilexetil 16 mg tablets in 90-count bottles, with a ceiling value of $4,854.63 and a period of performance through March 12, 2025. The contract does not have a set-aside designation, indicating open competition. This delivery order is part of a larger Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Candesartan Cilexetil 32 mg tablets. The award has a ceiling value of $50,181.52 and a performance period through January 14, 2025. The contract is not designated as a set-aside and appears to be an open competition award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 32 mg tablets in 90-count packages, with a ceiling value of $7,726.48 and a period of performance through June 18, 2025. The contract is a firm-fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is the prime...
- This is a $31,487.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,824,771 units of Candesartan Cilexetil 16 mg tablets. The contract has a completion date of January 3, 2025 and was awarded on January 2, 2025. This delivery order is part of a larger $999,999,999 indefinite delivery contract (IDC) that Amerisourcebergen...